Compare First Citizens BancShares Inc (FCNCA) vs 22nd Century Group Inc (XXII) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
First Citizens BancShares Inc vs 22nd Century Group Inc — how do they compare? First Citizens BancShares Inc trades at $2,277.57 (market cap $25.04B), while 22nd Century Group Inc trades at $4.33 (market cap $1.52M). The key difference: First Citizens BancShares Inc is far larger — about 16473.7× 22nd Century Group Inc's market cap, and First Citizens BancShares Inc pays a 0.37% dividend while 22nd Century Group Inc pays none. Which is the better fit depends on your goals.
| FCNCA | XXII | |
|---|---|---|
Market Cap | $25.04B | $1.52M |
Sector | Sector/Thematic | Technology |
52-Week High | $2.25K | $801.00 |
52-Week Low | $1.64K | $3.72 |
Dividend Yield | 0.37% | — |
Enterprise Value | — | -$6.71M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
First Citizens BancShares (FCNCA) trades at $2,276, up 1.91% today, with a bullish technical signal from moving averages. The stock shows strong fundamentals with a P/E of 12.08 and net income margin of 25.23%, supported by recent earnings beats. Recent news highlights business expansion, including new financing groups and real estate acquisitions.
Outlook is positive with analyst consensus price target of $2,310, though most analysts rate it Hold. Key risks include elevated uninsured deposits and net interest margin pressure. Earnings growth and strategic initiatives provide upside potential, but investor caution is warranted near current levels.
XXII trades at $4.38, up 0.69% with neutral technical signals. The company shows concerning fundamentals with negative profit margins (-65.76% net income margin) and ROE of -130.19%, though valuation ratios appear low (P/S 0.03, P/B 0.07). Recent corporate actions include a 20:1 reverse stock split in June 2026. Analyst sentiment remains positive with 75% buy ratings, while the company expands VLN® product distribution in key markets like California and New York.
The outlook remains speculative given persistent losses despite revenue generation. Investment opportunity lies in successful execution of reduced-nicotine cigarette expansion and FDA regulatory progress. Key risks include continued cash burn, competitive pressures, and dependency on regulatory approvals for growth catalysts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About First Citizens BancShares Inc
First Citizens BancShares is a major US regional bank providing diverse financial services. It recently expanded significantly by acquiring the assets and liabilities of Silicon Valley Bank.
Read more on FCNCA →About 22nd Century Group Inc
22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →
